Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
      0.100p
  • 52 Week High: 13.80
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 997,127
  • Market Cap: £23.01m

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
02-Jan-25 Shore Capital House Stock 4.27p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.30p
Change Today 0.100p
% Change 3.13 %
52 Week High 13.80
52 Week Low 2.40
Volume 997,127
Shares Issued 697.20m
Market Cap £23.01m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.13% below the market average54.13% below the market average54.13% below the market average54.13% below the market average54.13% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Price Trend
89.98% below the market average89.98% below the market average89.98% below the market average89.98% below the market average89.98% below the market average
65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average65.22% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 27-Jun-2025

Time Volume / Share Price
16:22 30,027 @ 3.32p
16:21 30,027 @ 3.32p
15:46 5,366 @ 3.25p
15:33 300,000 @ 3.38p
15:29 47,144 @ 3.26p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page